Oral tacrolimus for the treatment of generalized morphea.

Abstract

1. Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571-6. 2. Aggarwal R, Lucas M, Fertig N, Oddis CV, Medsger TA Jr.. Anti-U3 RNP autoantibodies in systemic sclerosis. Arthritis Rheum 2009; 60: 1112-8. 3. Jawitz JC, Albert MK… (More)
DOI: 10.1684/ejd.2015.2689

Cite this paper

@article{Hirohata2016OralTF, title={Oral tacrolimus for the treatment of generalized morphea.}, author={Ayaki Hirohata and Takaaki Hanafusa and Ken Igawa and Tomoko Inoue-Nishimoto and Eriko Mabuchi-Kiyohara and Masayuki Nishide and Hiroo Yokozeki and Ryuta Ikegami}, journal={European journal of dermatology : EJD}, year={2016}, volume={26 1}, pages={112-3} }